Uitgebreid zoeken
Instrumenten
Naam | Mnemo | Beurs | Gemiddeld volume | Koers | Type | |
---|---|---|---|---|---|---|
ELISA OYJ | ELISA | Nasdaq Helsinki +6 Andere | 294 658 | 42,7 EUR | Aandeel | |
ELISA OYJ | EIA | Deutsche Boerse AG | 24 | 42 EUR | ||
ELISA OYJ | 0I8Y | London S.E. | - | 42,65 EUR | ||
ELISA OYJ | EIA | Börse Stuttgart | - | 42,24 EUR | ||
ELISA OYJ | EIA | BOERSE MUENCHEN | - | 42,8 EUR | ||
ELISA OYJ | ELMU.F | OTC Markets | 629 | 45,16 USD | ||
ELISA OYJ | EIA | Berne S.E. | - | - CHF | ||
ELISA OYJ | ELMU.Y | OTC Markets | 27 | 24 USD | Aandeel | |
ELISA OYJ (EI6) - ELA/C2 | Euronext Amsterdam | - | 42,56 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C5 | Euronext Amsterdam | - | 42,18 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C6 | Euronext Amsterdam | - | 42,53 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20241220 | Euronext Amsterdam | - | 42,47 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C1 | Euronext Amsterdam | - | 42,4 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C3 | Euronext Amsterdam | - | 42,64 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C4 | Euronext Amsterdam | - | 42,92 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20240620 | Euronext Amsterdam | - | 42,8 EUR | Future |
Bedrijven (17)
Beijing Wantai Biopharmaceutical Co, Ltd. is een onderneming die zich voornamelijk bezighoudt met onderzoek en ontwikkeling, productie en verkoop van in-vitro diagnostica. De Onderneming produceert en verkoopt in-vitro diagnostica, in-vitro diagnostische ...
Elisa Oyj is het nummer 1 particuliere telecommunicatiebedrijf in Finland. De netto-omzet is als volgt over de verschillende activiteiten verdeeld - mobiele telefoondienst (59,2%); - vaste telecommunicatie (40,8%): vaste telefoondienst en breedband inte ...
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is een in Turkije gevestigd bedrijf dat zich bezighoudt met onderzoek, ontwikkeling en productie van in-vitro diagnostiek. Zijn diagnostische producten omvatten: Klinische Microbiologi ...
Bioporto A/S is een in Denemarken gevestigd bedrijf dat zich bezighoudt met de ontwikkeling en marketing van in-vitro diagnostische (IVD) assays. Het portfolio van het bedrijf omvat vijf productcategorieën: De Neutrophil gelatinase-associated lipocalin (N ...
Quanterix Corporation is een biowetenschappelijk bedrijf. Het bedrijf houdt zich bezig met de ontwikkeling van ultragevoelige digitale immunoassay-platforms die precisiegezondheid bevorderen voor biowetenschappelijk onderzoek en diagnostiek. De platforms ...
Soprocal Calerias e Industrias SA is een Chileense onderneming die zich bezighoudt met de aankoop en exploitatie van minerale afzettingen en de productie van calciumcarbonaat, ongebluste kalk, ongebluste kalk, hydraulische kalk en andere verwante derivate ...
AroCell publ AB is een in Zweden gevestigd diagnostisch bedrijf dat zich bezighoudt met de ontwikkeling van markers voor het bepalen van celgroei (TK 210) en apoptose. De belangrijkste productkandidaat van het bedrijf, TK-immuno/hem, is een test voor het ...
Cheilbio Co., Ltd. is een in Korea gevestigd bedrijf dat zich bezighoudt met de productie van diergeneesmiddelen. Het aanbod van het bedrijf bestaat uit antibiotica, antimicrobiële middelen, lactobacillus, enzympreparaten, parasiticiden, antiseptica, orga ...
American Vietnamese Biotech Incorporation (AmviBiotech) is een in Vietnam gevestigd bedrijf dat zich bezighoudt met de farmaceutische industrie. De onderneming is betrokken bij de productie van geneesmiddelen, vaccins en biologische producten. Het is ook ...
1000mercis is gespecialiseerd in het leveren van interactieve reclame- en marketingdiensten. De netto-omzet is als volgt over de verschillende activiteiten verdeeld - interactieve marketingdiensten (45,2%): ontwikkelen van marktsegmentonderzoeken en tevr ...
Shenzhen Bioeasy Biotechnology Co Ltd is een in China gevestigd bedrijf dat zich voornamelijk bezighoudt met onderzoek, ontwikkeling, productie, verkoop en levering van testproducten voor voedselveiligheid en aanverwante diensten. De belangrijkste product ...
Bioqual, Inc. houdt zich bezig met contractonderzoek, gericht op in vivo modellen van menselijke ziekten, waaronder COVID-19, verworven immunodeficiëntiesyndroom (AIDS), influenza, Mpox, respiratoir syncytieel virus (RSV) infectie, Flavivirusinfecties, wa ...
Spring Art Holdings Berhad is een in Maleisië gevestigde beleggingsholding. Via haar dochteronderneming Spring Art Industries Sdn. Bhd. houdt de onderneming zich voornamelijk bezig met de productie van kant-en-klare meubelproducten, waarbij zij zich bezig ...
Bioventix plc is een in het Verenigd Koninkrijk gevestigd bedrijf dat gespecialiseerd is in de ontwikkeling en commerciële levering van hoogaffinitaire monoklonale antilichamen voor toepassingen in de klinische diagnostiek, zoals in geautomatiseerde immun ...
Aptamer Group plc is een in het Verenigd Koninkrijk gevestigd bedrijf dat affiniteitsbinders op maat ontwikkelt via zijn Optimer-platform om nieuwe benaderingen in therapeutica, diagnostiek en onderzoekstoepassingen mogelijk te maken. Het Optimer-platform ...
ViroGates A/S is een in Denemarken gevestigd medisch-technisch bedrijf. Het ontwikkelt een productlijn suPARnostic, die de hoeveelheid oplosbaar urokinase Plasminogen Activator Receptor-eiwit (suPAR) in het menselijk bloed meet. Het plasmagehalte van suPA ...
Diadexus, Inc. is een diagnostisch bedrijf. Het bedrijf houdt zich bezig met het ontwikkelen en op de markt brengen van producten die zorgverleners voorzien van relevante informatie om te helpen bij de behandeling van patiënten tijdens het verloop van har ...
Insiders
Momenteel bekleedt Elisa Patrizi de functie van Head-Operations & Maintenance bij Infrastrutture Wireless Italiane SpA. In het verleden was mevrouw Patrizi Manager-Wireless Development bij Telecom Italia SpA. Zij behaalde een bachelordiploma aan de Universit degli Studi di Roma Tor Vergata.
Francesco Patrizi currently works as a Chief Executive Officer & Director at Società Emiliana Trasporti Autofiloviari S.p.A.
Tony Marco Patrizi is the founder of GR Engineering Services Ltd., a company he founded in 2006.
He currently holds the title of Managing Director & Executive Director at the firm.
In addition to his founding position, Mr. Patrizi has also held former positions.
From 2016 to 2018, he served as an Independent Non-Executive Director at Primary Gold Ltd.
He also worked as an Operations Manager at JR Engineering Services Pty Ltd.
Marco Anselmo Patrizi currently works at Morison KSi Ltd., as Director.
Scott Patrizi is a professional with experience in various non-executive director roles.
He is currently a Non-Executive Director at Forrestania Resources Ltd.
Prior to this, he was the President, Chief Executive Officer & Director at Huntsman Exploration, Inc. from 2021 to 2023.
He also served as a Non-Executive Director at Elixir Energy Ltd.
from 2016 to 2019, and at Rarex Ltd.
from 2016 to 2020.
Additionally, he briefly served as a Non-Executive Director at Caprice Resources Ltd.
in 2021.
Patrizi holds an undergraduate degree from The University of Western Australia Business School.
Elisa currently works at PT Metro Healthcare Indonesia Tbk, as Manager-Finance & Accounting.
Elisa Lee worked as an Attorney at Latham & Watkins LLP from 2000 to 2008.
She then worked as Senior Counsel at The Cooper Cos., Inc. in 2008 and as Assistant General Counsel at CooperVision, Inc. in 2009.
From 2009 to 2014, she worked at ICE Mortgage Technology, Inc. as Secretary, Executive VP & General Counsel.
She also worked as Secretary & Chief Legal Officer at Plex Systems, Inc. Ms. Lee holds an undergraduate degree from the University of California, Berkeley and a graduate degree from New York University.
Elisa B.
Gesalta worked as a Vice President at PLDT, Inc. from 2006 to 2020.
She obtained an undergraduate degree from the University of Santo Tomas.
Elisa Corghi is currently an Independent Director at Recordati SpA.
She also holds director positions at Nexi Payments SpA, Nexi SpA, Pitti Immagine Srl, Corneliani SpA, and RE Valuta SpA.
Previously, she served as an Independent Director at BasicNet SpA and Tinexta SpA.
Ms. Corghi's former roles include Senior Brand Manager-Sottilette Kraft at Mondelez International, Inc., Analyst at Intermonte Sim SpA, and Brand Manager at Barilla Alimentare SpA.
She obtained her undergraduate degree from the University of Bocconi in 1996.
Elisa Nardi worked as a Managing Director-People at Virgin Media, Inc. and as a Chief People Officer at The British United Provident Association Ltd.
Elisa Hebb is currently the EVP-Clinical Development & Regulatory Affairs at Endologix LLC since 2018.
Prior to this, she held the position of Vice President-Clinical & Regulatory Affairs at Crux Biomedical, Inc. starting in 2008 and Vice President-Clinical Affairs at Apneon, Inc. starting in 2007.
Ms. Hebb's former positions include Director-Clinical Programs at Boston Scientific Corp., Senior Director-Global Clinical Affairs at Philips Image Guided Therapy Corp.
from 2014 to 2015, and Senior Director-Clinical Affairs at Wallace Enterprises, Inc. Ms. Hebb completed her undergraduate degree at the University of California, Berkeley.
Elisa Bruce has worked as a Vice President at Fifth Third Bank, NA in Cincinnati, Ohio.
Elisa Lumbantoruan currently works at PT ISS Indonesia, as President Director & Chief Executive Officer from 2015 and PT Indosat Tbk, as Independent Commissioner from 2022.
Mr. Lumbantoruan also formerly worked at PT Garuda Indonesia (Persero) Tbk, as Executive VP, Director-Marketing & Sales from 2012 to 2013, PT Compaq Computer Indonesia, as Director-Marketing, PT Digital Astra Nusantara, as Director-Marketing, PT Hewlett-Packard Financial Services, as Director, PT Hewlett-Packard Indonesia, as President Director from 2002 to 2007, PT Samora Usaha Makmur, as EVP, Director-Human Capital, IT & Strategy, PT Astra Graphia Tbk, as Manager-Accounts, PT XL Axiata Tbk, as Independent Commissioner from 2008 to 2012, PT Garuda Indonesia (Persero) Tbk, as Independent Commissioner, Oracle Systems Asia Tenggara Pte Ltd., as Manager-Country Alliance, PT Cipta Arta Graha Informasi, as Manager-Sales, PT Gapura Angkasa, as President Commissioner from 2012 to 2013, and PT Citilink Indonesia, as President Commissioner from 2008 to 2013.
Mr. Lumbantoruan received his undergraduate degree in 1985 from Institut Teknologi Bandung.
Elisa Albendea currently works as a Marketing Manager at DSG Ireland Ltd.
Elisa Schupp has worked as a Director at the Canadian Investor Relations Institute since 2012 and as Vice President-Channels & Strategic Sales at CNW Group Ltd.
since 1984.
Elisa Freeman worked as a Senior Vice President-Distribution Operations at Discovery, Inc.
Elisa Belgacem worked as a Quantitative Researcher at Crédit Agricole Corporate & Investment Bank SA from 2013 to 2019.
She also worked as a Strategist at Crédit Agricole Cheuvreux SA.
Elisa Crotti is currently a Partner at RNT Invest Srl, Ticinese Building Srl, and Moffu Labs 2 Srl.
Previously, she worked as an Independent Director at SECO SpA, a Principal at The Boston Consulting Group, Inc., and an EVP-Strategy & Business Development at The Nuance Group AG.
Ms. Crotti holds an MBA from INSEAD and an undergraduate degree from Politecnico di Milano (conferral date: 1998).
Elisa Federspiel has founded Vigilent Corp.
in 2008, where she currently holds the title of Vice President-People & Operations.
She has worked as a Principal at Chancellor Corp., Assistant VP-Firstar Capital Markets Group at U.S.
Bancorp, Syndication Manager at MUFG Americas Leasing Corp., and Syndications Representative at John Hancock Leasing Corp.
Ms. Federspiel completed her undergraduate degree at Northeastern University.
Elisa Kruger worked as a Sales Manager at Panera Bread Co. from 2012 to 2013.
Elisa LeNoir
CHIEF COMPLIANCE OFFICER
Elisa is the Chief Compliance Officer at Lead Edge Capital.
Prior to joining Lead Edge, she was the Compliance Associate at JANA Partners LLC, an investment manager focusing on event-driven investing.
Elisa received her B.S.
in Psychology from the University of Florida, and her M.A.
in International Psychology from The Chicago School of Professional Psychology.
Elisa Manassa has a current job as the Head-Accounting at Yolo Group SpA.
Elisa Valeriani has a current job as an Independent Director at BPER Banca SpA.
Elisa Velazquez currently works as a Trustee for the New Jersey Dental Association.
Currently, she holds a job as a Trustee for the same organization.
Elisa Heslop currently works at Greenwich House, Inc., as Director from 2017.
Elisa Imelda has a current job as the Head of Finance, Accounting & Tax at PT Uni-Charm Indonesia Tbk.
Elisa Denise Turcot has worked as a Secretary at Green Mining Innovation, Inc. since 2023.
Elisa Baroncini is currently an Independent Non-Executive Director at Eni SpA.
She is also a Professor of International Law at Alma Mater Studiorum - Università di Bologna and a Member at World Investment Srl.
Previously, she served as the Co-Chairman of International Economic Law at the European Society of International Law from 2012 to 2022.
Elisa Janine Nasho currently works at Aviva Central Services UK Ltd., as Director from 2023.
Ms. Elisa A.
Mazen is a Managing Director, Head of Global Growth & Portfolio Manager at ClearBridge Investments LLC and at ClearBridge LLC.
In ClearBridge LLC, she is the head of firm's Global Growth Equity investment team and co-manages numerous global and international growth strategies.
In ClearBridge she is responsible for covering the consumer sector for firm's international and global growth portfolios.
She has over 39 years of investment industry experience.
Ms. Mazen joined ClearBridge from predecessor firm Global Currents Investment Management, which was founded in 2008 by a group of portfolio managers from Brandywine Global Investment Management.
Prior to joining Global Currents, she was a Managing Director and Head of the International and Global Equity Investments Group at Oppenheimer Capital, a division of Allianz Global Investors.
In addition, she was Executive Vice President and Portfolio Manager for the Central European Value Fund and had responsibility for a number of other funds at the firm.
Prior to Oppenheimer, she was a portfolio manager at Clemente Capital where she managed assets for public pension funds.
She began her career at Mitchell Hutchins Asset Management, now a subsidiary of UBS, in the High Yield investment area.
Ms. Mazen received her BA in Economics and Finance from Douglass College, Rutgers University.
Elisa O.
Abalajon is currently the Chief Human Resources Officer at Universal Robina Corp.
Her former job was as HR Director-Southeast Asia at Mondelez International AMEA Pte Ltd.
She received her undergraduate degree from Singapore Management University in 2013 and also attended Ateneo De Manila Law School for undergraduate studies.
Elisa Govi is the founder and Chief Executive Officer of Ciesse Paper SRL, which is founded in 1947.
Elisa Vall is currently a Director at Egis Group.
She previously worked as a Director at Egis SA.
Elisa Luciano has held positions as an Independent Director at Societa' Reale Mutua di Assicurazioni and as a Director at Italiana Assicurazioni SpA.
Elisa Stude Pye currently works as a Director at the Houston Arboretum & Nature Center.
Geen resultaten voor deze zoekopdracht
- Beurs
- Uitgebreid zoeken
- Elisa Patrizi